QUOTE AND NEWS
Forbes  May 24  Comment 
A particularly strong insider buying signal is what we call a "cluster-buy" where three or more different insiders make open market purchases within a short period of one another. At Amedisys, Inc. (NASD: AMED), 4 different insiders purchased...
Benzinga  May 15  Comment 
Jefferies reduces its price target from $15 to $12 on Hold-rated Amedisys (NASDAQ: AMED) as it believes a Stark Law violation will keep the company grounded for the time being. Jefferies says, "A 10-Q disclosure that AMED self-reported to CMS...
  May 10  Comment 
Reprint of Original Article from July 15th 2010... OpenTable (OPEN) and Amedisys (AMED) - What would you do with these two stocks? Here are their charts. OpenTable looks like a rocket ship taking off! Amedisys looks like a...
Benzinga  May 9  Comment 
Jefferies reduces its price target from $16.50 to $15 on Hold-rated Amedisys (NASDAQ: AMED) as reimbursement uncertainty offsets on-track restructuring at the company. Jefferies notes, "AMED continues to make progress with its restructuring...
Business Wire  May 8  Comment 
Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today reported its financial results for the first quarter ended March 31, 2012. Three-Month Periods Ended March 31, 2012 and 2011 Net service revenue of $370.8 million
Business Wire  Apr 10  Comment 
Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today announced details for its earnings release and conference call for the first quarter ended March 31, 2012. The Company plans to issue its earnings release prior to the
Benzinga  Mar 21  Comment 
Jefferies raises its price target $5.50 to $16.50 on Hold-rated Amedisys (NASDAQ: AMED) to reflect benefit from agency rationalization efforts. Jefferies says, "We expect AMED to realize a $20MM earnings benefit this year from its agency...
Benzinga  Feb 29  Comment 
Shares of Amedisys (NASDAQ: AMED) are higher on the session by 2.89%, currently trading at $12.81. The stock has been moving largely higher over the past five weeks and is currently trading above the 50-day moving average. Options traders are...
Business Wire  Feb 28  Comment 
Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today reported its financial results for the fourth quarter and year ended December 31, 2011 and issued 2012 guidance. Three-Month Periods Ended December 31, 2011 and 2010
Business Wire  Feb 27  Comment 
Amedisys, Inc. (NASDAQ: AMED) today announced it is now a home health and hospice care provider for United Healthcare across the southeast including Alabama, Florida, Georgia, Mississippi, North Carolina and Tennessee. Becoming an in-network provider




 
TOP CONTRIBUTORS

Amedisys, Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population. As of December 31, 2010, the company owned and operated 486 Medicare-certified home health agencies and 67 Medicare-certified hospice agencies in 45 states within the United States, the District of Columbia, and Puerto Rico. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Industry

Company

Segments

Home Health Care

The company’s home care services include skilled nursing, home health aides, physical and occupational therapy, speech therapy, and medical social workers; and specialized nursing programs, such as cardiac, diabetes, pain management, wound care, infusion therapy, oncology, and psychiatric services. It also provides a portfolio of chronic care clinical programs designed from evidence-based best practices for patients with chronic diseases.

Hospice

The company’s hospice care team includes patient and family, attending physician, hospice physician, nurses, social workers, home health aides, volunteers, bereavement counselors, and spiritual counselors, as well as physical, speech, and occupational therapists. It provides hospice services to individuals with a terminal illness, such as heart disease, pulmonary disease, dementia, Alzheimer’s, HIV/AIDS, or cancer.

Trends & Forces

US Federal Subsidies

Cuts

Due to persistent high Federal spending, deficits, and debt, efforts have been made to reduce wasteful subsidization by intent even though legitimate expenditures may have also been reduced. These Federal legislations are more uncommon than not and have not been repeated recently.

Obamacare

Seemingly due to the enormous length of the legislation, the full extent of the effects of it are not yet fully known; nevertheless, Federal spending on healthcare is the largest percentage by far and has maintained a steady rate of increase.

References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki